New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
Activate Your Account with an access code or Create a New Account
Anna Lembke
Psychiatrist
Associate Professor of Psychiatry and Behavioral Sciences (General Psychiatry and Psychology-Adult) and, by courtesy, of Anesthesiology, Perioperative and Pain Medicine at the Stanford University Medical Center
Bio:
Dr. Anna Lembke received her undergraduate degree in Humanities from Yale University and her medical degree from Stanford University. She is on the faculty of the Stanford University School of Medicine, a diplomate of the American Board of Psychiatry and Neurology, and a diplomate of the American Board of Addiction Medicine. She is the Program Director for the Stanford University Addiction Medicine Fellowship, and Chief of the Stanford Addiction Medicine Dual Diagnosis Clinic. She has published over 50 peer-reviewed articles, chapters, and commentaries, including in the New England Journal of Medicine, the Journal of the American Medical Association, the Journal of General Internal Medicine, and Addiction. Dr. Lembke sees patients, teaches, and does research. She is the author of a book on the prescription drug epidemic: “Drug Dealer, MD: How Doctors Were Duped, Patients Got Hooked, and Why It’s So Hard to Stop” (Johns Hopkins University Press, October 2016).
Dr. Anna Lembke's key areas of interest include treating patients who have become addicted to prescription drugs. She takes a holistic, harm-reduction approach to each patient, and encourages spiritual and alternative therapies in the process of healing.
Dr. Anna Lembke's key areas of interest include treating patients who have become addicted to prescription drugs. She takes a holistic, harm-reduction approach to each patient, and encourages spiritual and alternative therapies in the process of healing.
- 401 Quarry Road
- Stanford , CA 94304
- Phone: 650-498-9111
- 401 Quarry Road
- Stanford , CA 94304
- Phone: 650-498-9111
Practice Areas
- Addiction Disorders
- Anxiety
- Bipolar Disorder
- Depression
- Pain
- Psychoanalytic Treatment
- Psychotherapy
- Schizophrenia
- Urine Toxicology
Professional Education
- Residency: Stanford University School of Medicine Registrar (2001) CA
- Residency: Stanford University School of Medicine Registrar (1997) CA
- Internship: Alameda County Medical Center / Univ of California San Francisco Affiiliated (1998) CA
- Board Certification: Addiction Medicine, American Board of Addiction Medicine (2012)
- Medical Education: Stanford University School of Medicine (1995) CA
- Board Certification: Psychiatry, American Board of Psychiatry and Neurology (2003)
Publications
-
Depression in Individuals with Epilepsy.
Barry, J. J., Huynh, N., & Lembke, A. (2000). Depression in Individuals with Epilepsy. Current Treatment Options in Neurology, 2(6), 571–585. -
Impaired recognition of facial emotion in mania
Lembke, A., & Ketter, T. A. (2002). Impaired recognition of facial emotion in mania. AMERICAN JOURNAL OF PSYCHIATRY, 159(2), 302–304. -
Olanzapine in diverse syndromal and subsyndromal exacerbations of bipolar disorders
Janenawasin, S., Wang, P. W., Lembke, A., Schumacher, M., Das, B., Santosa, C. M., … Ketter, T. A. (2002). Olanzapine in diverse syndromal and subsyndromal exacerbations of bipolar disorders. BIPOLAR DISORDERS, 4(5), 328–334. -
Neural correlates of timbre change in harmonic sounds
Menon, V., Levitin, D. J., Smith, B. K., Lembke, A., Krasnow, B. D., Glazer, D., … McAdams, S. (2002). Neural correlates of timbre change in harmonic sounds. NEUROIMAGE, 17(4), 1742–1754.
-
Safety of antidepressants in the elderly.
Sommer, B. R., Fenn, H., Pompei, P., DeBattista, C., Lembke, A., Wang, P., & Flores, B. (2003). Safety of antidepressants in the elderly. Expert Opinion on Drug Safety, 2(4), 367–383.
-
A Friday in the life of an academic psychiatrist
Lembke, A. (2003). A Friday in the life of an academic psychiatrist. ACADEMIC PSYCHIATRY, 27(3), 214–215.
-
A prospective trial of modafinil as an adjunctive treatment of major depression
DeBattista, C., Lembke, A., Solvason, H. B., Ghebremichael, R., & Poirier, J. (2004). A prospective trial of modafinil as an adjunctive treatment of major depression. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 24(1), 87–90.
-
Current status of the utilization of antiepileptic treatments in mood, anxiety and aggression: Drugs and devices
Barry, J. J., Lembke, A., & Bullock, K. D. (2004). Current status of the utilization of antiepileptic treatments in mood, anxiety and aggression: Drugs and devices. CLINICAL EEG AND NEUROSCIENCE, 35(1), 4–13.
-
Psychosocial service utilization by patients with bipolar disorders: data from the first 500 participants in the Systematic Treatment Enhancement Program.
Lembke, A., Miklowitz, D. J., Otto, M. W., Zhang, H., Wisniewski, S. R., Sachs, G. S., … Ketter, T. A. (2004). Psychosocial service utilization by patients with bipolar disorders: data from the first 500 participants in the Systematic Treatment Enhancement Program. Journal of Psychiatric Practice, 10(2), 81–87.
-
Why is this special issue on women's professional development in psychiatry necessary?
Lembke, A. (2004). Why is this special issue on women's professional development in psychiatry necessary? ACADEMIC PSYCHIATRY, 28(4), 275–277.
-
Update on augmentation of antidepressant response in resistant depression.
DeBattista, C., & Lembke, A. (2005). Update on augmentation of antidepressant response in resistant depression. Current Psychiatry Reports, 7(6), 435–440.
-
Depression and smoking cessation: does the evidence support psychiatric practice?
Lembke, A., Johnson, K., & DeBattista, C. (2007). Depression and smoking cessation: does the evidence support psychiatric practice? Neuropsychiatric Disease and Treatment, 3(4), 487–493.
-
Alcohol Screening Scores and the Risk of New-Onset Gastrointestinal Illness or Related Hospitalization
Lembke, A., Bradley, K. A., Henderson, P., Moos, R., & Harris, A. H. S. (2011). Alcohol Screening Scores and the Risk of New-Onset Gastrointestinal Illness or Related Hospitalization. JOURNAL OF GENERAL INTERNAL MEDICINE, 26(7), 777–782.
-
The mineralocorticoid receptor agonist, fludrocortisone, differentially inhibits pituitary-adrenal activity in humans with psychotic major depression
Lembke, A., Gomez, R., Tenakoon, L., Keller, J., Cohen, G., Williams, G. H., … Schatzberg, A. F. (2013). The mineralocorticoid receptor agonist, fludrocortisone, differentially inhibits pituitary-adrenal activity in humans with psychotic major depression. PSYCHONEUROENDOCRINOLOGY, 38(1), 115–121.
-
Time to Abandon the Self-Medication Hypothesis in Patients with Psychiatric Disorders
Lembke, A. (2012). Time to Abandon the Self-Medication Hypothesis in Patients with Psychiatric Disorders. AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE, 38(6), 524–529.
-
Why Doctors Prescribe Opioids to Known Opioid Abusers
Lembke, A. (2012). Why Doctors Prescribe Opioids to Known Opioid Abusers. NEW ENGLAND JOURNAL OF MEDICINE, 367(17), 1580–1581.
-
Altered brain function underlying verbal memory encoding and retrieval in psychotic major depression.
Kelley, R., Garrett, A., Cohen, J., Gomez, R., Lembke, A., Keller, J., … Schatzberg, A. (2013). Altered brain function underlying verbal memory encoding and retrieval in psychotic major depression. Psychiatry Research, 211(2), 119–126.
-
From self-medication to intoxication: time for a paradigm shift.
Lembke, A. (2013). From self-medication to intoxication: time for a paradigm shift. Addiction , 108(4), 670–671.
-
Isolated meningeal vasculopathy associated with Clostridium septicum infection
Crowley, R. S., Lembke, A., & Horoupian, D. S. (1997). Isolated meningeal vasculopathy associated with Clostridium septicum infection. NEUROLOGY, 48(1), 265–267.
-
The status of evidence-based guidelines and algorithms in the treatment of depression
Debattista, C., Trivedi, M. H., Kern, J. K., & Lembke, A. (2002). The status of evidence-based guidelines and algorithms in the treatment of depression. PSYCHIATRIC ANNALS, 32(11), 658–663.
-
Psychotherapy, symptom outcomes, and role functioning over one year among patients with bipolar disorder
Miklowitz, D. J., Otto, M. W., Wisniewski, S. R., Araga, M., Frank, E., Reilly-Harrington, N. A., … Sachs, G. S. (2006). Psychotherapy, symptom outcomes, and role functioning over one year among patients with bipolar disorder. PSYCHIATRIC SERVICES, 57(7), 959–965.
-
The relationships of positive and negative symptoms with neuropsychological functioning and their ability to predict verbal memory in psychotic major depression
Che, A. M., Gomez, R. G., Keller, J., Lembke, A., Tennakoon, L., Cohen, G. H., & Schatzberg, A. F. (2012). The relationships of positive and negative symptoms with neuropsychological functioning and their ability to predict verbal memory in psychotic major depression. PSYCHIATRY RESEARCH, 198(1), 34–38.
-
Why doctors prescribe opioids to known opioid abusers. How cultural attitudes and financial disincentives affect the prescribing habits of physicians.
Lembke, A. (2013). Why doctors prescribe opioids to known opioid abusers. How cultural attitudes and financial disincentives affect the prescribing habits of physicians. Minnesota Medicine, 96(3), 36–37.
-
HPA axis genetic variation, cortisol and psychosis in major depression.
Schatzberg, A. F., Keller, J., Tennakoon, L., Lembke, A., Williams, G., Kraemer, F. B., … Murphy, G. M. (2014). HPA axis genetic variation, cortisol and psychosis in major depression. Molecular Psychiatry, 19(2), 220–227.
-
Plasma oxytocin concentrations are lower in depressed vs. healthy control women and are independent of cortisol.
Yuen, K. W., Garner, J. P., Carson, D. S., Keller, J., Lembke, A., Hyde, S. A., … Parker, K. J. (2014). Plasma oxytocin concentrations are lower in depressed vs. healthy control women and are independent of cortisol. Journal of Psychiatric Research, 51, 30–36.
-
Pharmacotherapy for Alcohol Dependence: Perceived Treatment Barriers and Action Strategies Among Veterans Health Administration Service Providers
Harris, A. H. S., Ellerbe, L., Reeder, R. N., Bowe, T., Gordon, A. J., Hagedorn, H., … Trafton, J. A. (2013). Pharmacotherapy for Alcohol Dependence: Perceived Treatment Barriers and Action Strategies Among Veterans Health Administration Service Providers. PSYCHOLOGICAL SERVICES, 10(4), 410–419.
-
Altered brain function underlying verbal memory encoding and retrieval in psychotic major depression
Kelley, R., Garrett, A., Cohen, J., Gomez, R., Lembke, A., Keller, J., … Schatzberg, A. (2013). Altered brain function underlying verbal memory encoding and retrieval in psychotic major depression. PSYCHIATRY RESEARCH-NEUROIMAGING, 211(2), 119–126.
-
Recovery-oriented policy and care systems in the UK and USA.
Humphreys, K., & Lembke, A. (2014). Recovery-oriented policy and care systems in the UK and USA. Drug and Alcohol Review, 33(1), 13–18.
-
Clinical management of alcohol use disorders in the neurology clinic.
Lembke, A., & Stanford, M. (2014). Clinical management of alcohol use disorders in the neurology clinic. Handbook of Clinical Neurology, 125, 659–670.
-
Assessment of provider attitudes toward #naloxone on Twitter.
Haug, N. A., Bielenberg, J., Linder, S. H., & Lembke, A. (2016). Assessment of provider attitudes toward #naloxone on Twitter. Substance Abuse, 37(1), 35–41.
-
A qualitative study of treatment-seeking heroin users in contemporary China.
Lembke, A., & Zhang, N. (2015). A qualitative study of treatment-seeking heroin users in contemporary China. Addiction Science & Clinical Practice, 10, 23-?
-
Weighing the Risks and Benefits of Chronic Opioid Therapy
Lembke, A., Humphreys, K., & Newmark, J. (2016). Weighing the Risks and Benefits of Chronic Opioid Therapy. AMERICAN FAMILY PHYSICIAN, 93(12), 982–990.
-
Retrospective analysis of changing characteristics of treatment-seeking smokers: implications for further reducing smoking prevalence.
Leyro, T. M., Crew, E. E., Bryson, S. W., Lembke, A., Bailey, S. R., Prochaska, J. J., … David, S. P. (2016). Retrospective analysis of changing characteristics of treatment-seeking smokers: implications for further reducing smoking prevalence. BMJ Open, 6(6).
-
Reasons for Benzodiazepine Use Among Persons Seeking Opioid Detoxification.
Stein, M. D., Kanabar, M., Anderson, B. J., Lembke, A., & Bailey, G. L. (2016). Reasons for Benzodiazepine Use Among Persons Seeking Opioid Detoxification. Journal of Substance Abuse Treatment, 68, 57–61.
